☰

Agnieszka D Czechowicz - Publications

Affiliations: 
Stanford University School of Medicine, Palo Alto, CA, United States 
Website:
https://www.stanfordchildrens.org/en/doctor/agnieszka-d-czechowicz
Tree Info Similar researchers PubMed Report error

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Swartzrock L, Dib C, Denis M, Willner H, Ho K, Haslett E, Han J, Pan W, Byrne-Steele M, Brown B, Krampf MR, Girsen A, Blumenfeld YJ, El-Sayed YY, Roncarolo MGG, ... ... Czechowicz AD, et al. In Utero Hematopoietic Stem Cell Transplantation for Fanconi Anemia. Blood Advances. PMID 38991119 DOI: 10.1182/bloodadvances.2023011894  0.74
2024 Sharma A, Czechowicz A, Mavers M, Chao N, DiPersio J, Reddy P, Perales MA, Smith M. Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task Force. Transplantation and Cellular Therapy. PMID 38608806 DOI: 10.1016/j.jtct.2024.04.005  0.325
2024 Denis M, Swartzrock L, Willner H, Bubb QR, Haslett E, Chan YY, Chen A, Krampf MR, Czechowicz AD. Hematopoiesis post anti-CD117 monoclonal antibody treatment in wild-type and Fanconi anemia settings. Haematologica. PMID 38572555 DOI: 10.3324/haematol.2023.284275  0.73
2023 Igarashi KJ, Kucinski I, Chan YY, Tan TK, Khoo HM, Kealy D, Bhadury J, Hsu I, Ho PY, Niizuma K, Hickey JW, Nolan G, Bridge KS, Czechowicz A, Gottgens B, et al. Physioxia improves the selectivity of hematopoietic stem cell expansion cultures. Blood Advances. PMID 36809781 DOI: 10.1182/bloodadvances.2023009668  0.822
2022 Chan YY, Ho PY, Swartzrock L, Rayburn M, Nofal R, Thongthip S, Weinberg KI, Czechowicz A. Non-Genotoxic Restoration of the Hematolymphoid System in Fanconi Anemia. Transplantation and Cellular Therapy. PMID 35995393 DOI: 10.1016/j.jtct.2022.08.015  0.747
2021 Ho PY, Zhang Z, Hayes ME, Curd A, Dib C, Rayburn M, Tam SN, Srivastava T, Hriniak B, Li XJ, Leonard S, Wang L, Tarighat S, Sim DS, Fiandaca M, ... ... Czechowicz A, et al. Peptide nucleic acid-dependent artifact can lead to false-positive triplex gene editing signals. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34732575 DOI: 10.1073/pnas.2109175118  0.759
2021 Cannon P, Asokan A, Czechowicz A, Hammond P, Kohn DB, Lieber A, Malik P, Marks P, Porteus M, Verhoeyen E, Weissman D, Weissman I, Kiem HP. Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development National Institutes of Health/Bill & Melinda Gates Foundation Expert Scientific Roundtable Webinar Meeting. Human Gene Therapy. PMID 33427035 DOI: 10.1089/hum.2020.263  0.547
2020 Bertaina A, Bacchetta R, Lewis DB, Grimm PC, Shah AJ, Agarwal R, Concepcion W, Czechowicz A, Bhatia N, Lahiri P, Weinberg KI, Parkman R, Porteus M, Roncarolo MG. Αβ T-Cell/CD19 B-Cell Depleted Haploidentical Stem Cell Transplantation: A New Platform for Curing Rare and Monogenic Disorders Biology of Blood and Marrow Transplantation. 26: S288. DOI: 10.1016/J.Bbmt.2019.12.560  0.553
2020 Czechowicz A, Rio P, Bueren JE, Beard B, Nicoletti E, Schwartz J, Soni S. Changing the Natural History of Fanconi Anemia Complementation Group-À with Gene Therapy: Early Results of U.S. Phase I Study of Lentiviral-Mediated Ex-Vivo FANCA Gene Insertion in Human Stem and Progenitor Cells Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.106  0.515
2019 Gao C, Schroeder JA, Xue F, Jing W, Cai Y, Scheck A, Subramaniam S, Rao S, Weiler H, Czechowicz A, Shi Q. Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice. Blood Advances. 3: 2700-2711. PMID 31515232 DOI: 10.1182/Bloodadvances.2019000516  0.719
2019 Kraft D, Walck E, Carrasco A, Crocker M, Song L, Long M, Mosse M, Nadeem B, Imanbyev G, Czechowicz A, McCullough M. The MarrowMiner: A Novel Minimally Invasive and Effective Device for the Harvest of Bone Marrow. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31491487 DOI: 10.1016/J.Bbmt.2019.08.027  0.837
2019 Pang WW, Czechowicz A, Logan AC, Bhardwaj R, Poyser J, Park CY, Weissman IL, Shizuru JA. Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice. Blood. PMID 30745302 DOI: 10.1182/Blood-2018-06-858159  0.855
2019 Czechowicz A, Palchaudhuri R, Scheck A, Hu Y, Hoggatt J, Saez B, Pang WW, Mansour MK, Tate TA, Chan YY, Walck E, Wernig G, Shizuru JA, Winau F, Scadden DT, et al. Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation. Nature Communications. 10: 617. PMID 30728354 DOI: 10.1038/S41467-018-08201-X  0.818
2019 Li Z, Czechowicz A, Scheck A, Rossi DJ, Murphy PM. Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation. Nature Communications. 10: 616. PMID 30728353 DOI: 10.1038/S41467-018-08202-W  0.848
2019 Lu R, Czechowicz A, Seita J, Jiang D, Weissman IL. Clonal-level lineage commitment pathways of hematopoietic stem cells in vivo. Proceedings of the National Academy of Sciences of the United States of America. PMID 30622181 DOI: 10.1073/Pnas.1801480116  0.834
2019 Kwon HS, Logan AC, Chhabra A, Pang WW, Czechowicz A, Tate K, Le A, Poyser J, Hollis R, Kelly BV, Kohn DB, Weissman IL, Prohaska SS, Shizuru JA. Anti-human CD117 antibody-mediated bone marrow niche clearance in non-human primates and humanized NSG mice. Blood. PMID 30617195 DOI: 10.1182/Blood-2018-06-853879  0.833
2019 Czechowicz A, Roncarolo MG, Beard BC, Law K, Nicoletti E, Río P, Bueren JA, Schwartz JD, Soni S. Changing the Natural History of Fanconi Anemia Complementation Group-A with Gene Therapy: Early Results of U.S. Phase I Study of Lentiviral-Mediated Ex-VivoFANCA Gene Insertion in Human Stem and Progenitor Cells Blood. 134: 3350-3350. DOI: 10.1182/Blood-2019-127352  0.426
2018 Czechowicz A, Palchaudhuri R, Scheck A, Hu Y, Winau F, Hoggatt J, Saez B, Mansour MK, Sykes D, Scadden D, Rossi D. Immune Sparing Conditioning for BMT/HSCT Using Anti-Ckit Immunotoxins Biology of Blood and Marrow Transplantation. 24: S60-S61. DOI: 10.1016/J.Bbmt.2017.12.633  0.787
2018 Pang WW, Czechowicz A, Poyser J, Park CY, Weissman IL, Shizuru JA. Anti-Human CD117 Antibodies Mediate Clearance of Myelodysplastic Syndrome Hematopoietic Stem Cells and Facilitate Establishment of Normal Hematopoiesis in Transplantation Biology of Blood and Marrow Transplantation. 24: S230-S231. DOI: 10.1016/J.Bbmt.2017.12.211  0.857
2016 Palchaudhuri R, Saez B, Hoggatt J, Schajnovitz A, Sykes DB, Tate TA, Czechowicz A, Kfoury Y, Ruchika F, Rossi DJ, Verdine GL, Mansour MK, Scadden DT. Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin. Nature Biotechnology. PMID 27272386 DOI: 10.1038/Nbt.3584  0.868
2016 Czechowicz A, Palchaudhuri R, Scheck A, Hoggatt J, Saez B, Scadden DT, Rossi DJ. Completely Non-Myeloablative/Non-Lymphoablative Conditioning for BMT/HSCT Using Anti-Ckit Immunotoxins Blood. 128: 493-493. DOI: 10.1182/Blood.V128.22.493.493  0.858
2016 McGovern PE, Czechowicz A, Mejaddam A, Stratigis JD, Li H, Urwin J, McClain LE, Zoltick PW, Flake AW, Peranteau WH. Enhanced Allogeneic Engraftment Achieved Via Prenatal Tolerance Induction and Postnatal Anti-CD45 Immunotoxin Conditioned Hematopoietic Cell Transplantation Blood. 128: 2153-2153. DOI: 10.1182/Blood.V128.22.2153.2153  0.587
2014 Dvorak CC, Horn BN, Puck JM, Adams S, Veys P, Czechowicz A, Cowan MJ. A trial of alemtuzumab adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency Pediatric Transplantation. 18: 609-616. PMID 24977928 DOI: 10.1111/Petr.12310  0.519
2014 Dvorak CC, Horn BN, Puck JM, Czechowicz A, Shizuru JA, Ko RM, Cowan MJ. A trial of plerixafor adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency. Pediatric Transplantation. 18: 602-8. PMID 24977650 DOI: 10.1111/petr.12309  0.418
2014 Derderian SC, Togarrati PP, King C, Moradi PW, Reynaud D, Czechowicz A, Weissman IL, MacKenzie TC. In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice. Blood. 124: 973-80. PMID 24879814 DOI: 10.1182/Blood-2014-02-550327  0.757
2013 Edris B, Willingham SB, Weiskopf K, Volkmer AK, Volkmer JP, Mühlenberg T, Montgomery KD, Contreras-Trujillo H, Czechowicz A, Fletcher JA, West RB, Weissman IL, van de Rijn M. Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth. Proceedings of the National Academy of Sciences of the United States of America. 110: 3501-6. PMID 23382202 DOI: 10.1073/Pnas.1222893110  0.744
2013 Derderian C, King C, Togarrati P, Czechowicz A, Lescano N, Reynaud D, Passegue E, Weissman IL, MacKenzie T. In Utero Depletion Of Fetal Host Hematopoietic Stem Cells Improves Engraftment Following Neonatal Transplantation In Mice Blood. 122: 3240-3240. DOI: 10.1182/Blood.V122.21.3240.3240  0.808
2012 Logan AC, Czechowicz A, Kelley BV, Thway TM, Magana I, Krampf MR, Poyser J, Hollis RP, Kohn DB, Weissman IL, Shizuru JA. Anti-CD117 (c-Kit) Monoclonal Antibodies Deplete Human Hematopoietic Stem Cells and Facilitate Their Replacement in Humanized NOD/SCID/IL2Rγ−/− Mice: A Non-Toxic Conditioning Regimen for Allotransplantation Blood. 120: 4099-4099. DOI: 10.1182/Blood.V120.21.4099.4099  0.789
2012 Lu R, Czechowicz A, Seita J, Weissman IL. Clonal Level Lineage Commitment of Mouse Hematopoietic Stem Cells in Vivo Blood. 120: 27-27. DOI: 10.1182/Blood.V120.21.27.27  0.819
2011 Czechowicz A, Weissman IL. Purified hematopoietic stem cell transplantation: the next generation of blood and immune replacement. Hematology/Oncology Clinics of North America. 25: 75-87. PMID 21236391 DOI: 10.1016/J.Hoc.2010.11.006  0.754
2011 Lu R, Czechowicz A, Weissman IL. Transplantation Conditioning Regimens Induce Different Hematopoietic Stem Cell Differentiation in Mice At the Clonal Level Blood. 118: 140-140. DOI: 10.1182/Blood.V118.21.140.140  0.807
2011 Czechowicz A, Bhardwaj R, Pang W, Park C, Weissman I. Targeted Clearance of Human Hematopoietic Stem Cell Niches Via Inhibition of SCF Signaling Using Monoclonal Antibody SR-1 Biology of Blood and Marrow Transplantation. 17: S187-S188. DOI: 10.1182/Blood.V116.21.74.74  0.864
2011 Ko R, Logronio K, Czechowicz A, Shizuru J. The Role of AMD3100 as a Preparative Regimen in Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation. 17: S306-S307. DOI: 10.1016/J.Bbmt.2010.12.456  0.664
2010 Czechowicz A, Weissman IL. Purified hematopoietic stem cell transplantation: the next generation of blood and immune replacement. Immunology and Allergy Clinics of North America. 30: 159-71. PMID 20493393 DOI: 10.1016/J.Iac.2010.03.003  0.754
2010 Ahn GO, Tseng D, Liao CH, Dorie MJ, Czechowicz A, Brown JM. Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proceedings of the National Academy of Sciences of the United States of America. 107: 8363-8. PMID 20404138 DOI: 10.1073/Pnas.0911378107  0.767
2009 Bhattacharya D, Czechowicz A, Ooi AG, Rossi DJ, Bryder D, Weissman IL. Niche recycling through division-independent egress of hematopoietic stem cells. The Journal of Experimental Medicine. 206: 2837-50. PMID 19887396 DOI: 10.1182/Blood.V114.22.79.79  0.858
2007 Czechowicz A, Kraft D, Weissman IL, Bhattacharya D. Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science (New York, N.Y.). 318: 1296-9. PMID 18033883 DOI: 10.1126/Science.1149726  0.808
2007 Rossi DJ, Seita J, Czechowicz A, Bhattacharya D, Bryder D, Weissman IL. Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle (Georgetown, Tex.). 6: 2371-6. PMID 17700071 DOI: 10.4161/Cc.6.19.4759  0.812
2007 Czechowicz A, Kraft DL, Bhattacharya D, Weissman IL. Antibody-Based Depletion of Hematopoietic Stem Cells Empties Niches for Efficient Transplantation. Blood. 110: LB2-LB2. DOI: 10.1182/Blood.V110.11.Lb2.Lb2  0.811
2007 Kraft D, Czechowicz A, Bhattacharya D, Weissman I. 196: Ability of anti c-Kit targeting monoclonal antibody ACK-2 to target hematopoietic stem cells, and facilitate engraftment of human CD34+ engraftment and hematolymphoid development in immunodeficient mice Biology of Blood and Marrow Transplantation. 13: 72. DOI: 10.1016/J.Bbmt.2006.12.200  0.754
2006 Kraft D, Czechowicz A, Weissman I. Adult human hematopoietic cells differentiate into mature T cells via a CD3-4+8- intermediate within the mouse thymic microenvironment; a new model system for the study of human thymocyte development further enhanced by anti-murine c-Kit mAB Biology of Blood and Marrow Transplantation. 12: 131. DOI: 10.1016/J.Bbmt.2005.11.404  0.628
2005 Kraft DL, Czechowicz A, Weissman IL. Adult Human Hematopoietic Cells Differentiate into Mature T Cells Via a CD3-4+8- Intermediate within the Mouse Thymic Microenvironment; a New Model System for the Study of Human Thymocyte Development. Blood. 106: 522-522. DOI: 10.1182/Blood.V106.11.522.522  0.643
Show low-probability matches.